MiR-301 is up-regulated in TNBC due to aberrant miR expression, and it promotes tumor growth, cell proliferation, migration, invasion, and tamoxifen resistance through the TLR4/NFkB signaling pathway [74]. The gene discussed is NFKB1; the disease is neoplasm.